Regular article
Influence of CPM-dependent sorting on the multi-omics profile of hepatocyte-like cells matured in microscale biochips

https://doi.org/10.1016/j.bej.2022.108408Get rights and content

Highlights

  • Hepatocytes-like cells were differentiated in Petri dishes, sorted, matured, and then inoculated in biochip.

  • Cells issued from sorted populations reached higher levels of maturation when compared to unsorted ones.

  • Transcriptomics, proteomics, and metabolomics profiles were characterized.

  • Characteristic pathways differentially expressed between cells issued from sorted and unsorted populations were analyzed.

Abstract

Liver modeling in disease via advanced in vitro physiological tissues remains a challenging issue, yet crucial for the future development of relevant tools for drug screening. In that regard, advanced technics such as human induced Pluripotent Stem Cells (hiPSCs) and organ-on-chip are promising technologies for the relevant reproduction of the in vivo micro physiology in in vitro culture conditions. In the present work, the maturation of carboxypeptidase M positive (CPM+) Hepatocyte-Like-Cells (HLCs) in microfluidic culture conditions was investigated. hiPSCs were differentiated in culture dishes until sorting and further amplified until seeding in biochips. After 2 weeks of maturation in biochips, evaluation of the cell metabolism was performed, and samples were collected for characterization via RNA sequencing, proteomics and metabolomics. The omics profile of biochips loaded with CPM+ HLCs was then compared with the one of previously cultured biochips loaded with unsorted HLCs. CPM+ HLCs presented advanced liver characteristics in terms of a higher activity of important Transcriptions Factors (TFs) such as HNF1, HNF4A, and CEBP/A, of the upregulation of steroids/corticoids-related nuclear receptors (FXR, NR3C2, NR4A1 genes), of phase I, and phase II metabolism genes (CYP1A1, CYP1B1, CYP2C18, CYP27A1, several UGT, SULT and GST genes). Further differences in the cellular reorganization, in the lipids and steroids metabolisms, in the OXPHOS respiration and in the expression of TGFβ signaling were also observed. The present study introduces a novel protocol using advances hiPSCs differentiation and sorting methods as well as the organ-on-chip technology to highlight important in vitro liver regeneration and hepatic maturation processes.

Introduction

The liver plays a central role in the metabolism of xenobiotics and in their detoxification while also being involved in regulation of lipids, proteins, and amino acids, in glucose homeostasis, and in bile synthesis [23]. In that regard, efficient in vitro models are highly sought for by industrials for drug testing purposes and by clinicians for the understanding of new mechanisms. Especially, microfluidics devices and organ on chip technologies are expected to be able to enhance the precision of prediction of drug safety and efficacy during preclinical tests by reproducing accurately the physiological environment of the targeted organ [32]. By doing so, the development of therapeutical solutions would not only be more accurate but also more cost-efficient which is a recurring issue for the industry [14]. However, numerous challenges in the field remain as compatibility with manufacturing processes and standardization is often low for these models [34] and will need to be solved once satisfying models have been developed. Focusing of the reproduction of the physiology of the liver, organ on chip must go through the reproduction of its microenvironment including the canals of Hering and the liver acinus. Of this, hepatic zonation-like patterns [1], [24], maintenance of primary hepatic cells for drug metabolism applications [7], and liver cocultures [38] have been proposed and have shown significant improvement of functionality of conventional culture methods. However, the combination of these models with new cutting-edge technologies in cell biology such as stem cells is still under investigation.

In that regard, hiPSCs-derived cells have been the topic of intensive research for the past few years as they are potentially allowed to differentiate into any cell type while being free from the constraint of limited cell number seen in primary cells harvested from donors. hiPSCs have also been combined with the organ on chip technology to form liver tissues, composed of Hepatocyte-Like Cells (HLCs), and which could be used for the improvement of the knowledge of liver homeostasis and liver regeneration processes as well as for the formation of mature in vitro liver tissue [11], [12], [18], [42], [45]. While the differentiation and maturation of hiPSCs-derived HLCs is expected to be enhanced by the culture in microfluidic devices either due to the presence of a physiological flow [48] or to the culture in confined environment [36], those cells still suffer from dominant patterns of primitiveness and are yet to lead to practical applications. A possible culprit for the unsatisfying maturation state of hiPSCs-derived cultures could be the low yield resulting from the differentiation process. A low yield in the differentiation would lead to the formation of a heterogeneous tissue which could have an uncontrolled effect on the behavior of HLCs. While positive effects have been observed [11], with the formation of an endothelial-like tissue, due to the effect of the shear stress from the microenvironment, control over the culture is needed to improve the reliability of those models for drug screening applications.

A possible strategy to increase control over the culture is cell sorting according to specific markers. Carboxypeptidase M (CPM) has been reported as a bipotential markers which led to the formation of highly functional, proliferating hepatocytes [25]. CPM+ cells are selected at the hepatic progenitor differentiation stage and can be amplified several times in culture dishes. The cells were then detached and inoculated in microfluidic biochips for maturation. Comparison of the function and of the transcriptome, proteome and metabolome profiles of those cells with previously published protocols (Unsorted HLCs matured in biochips, data published in [12]) was then performed and the influence of sorting for CPM positive populations was investigated. The analysis has led to a clear separation between the two conditions and improvements of the maturation in the CPM+ HLCs model could be confirmed by both the functional analysis and the multiomics analysis. The dataset presented in this study is of value toward the improvement of the culture of HLCs within microfluidic environment and should lead toward efficient liver on chip models for pharmaceutical applications.

Section snippets

hiPSCs cell source

In this study, the hiPSCs used were obtained from the stem cell bank of the Institute of Medical Science of the University of Tokyo (TKDN4-M clones, established by [47], using a retrovirus harboring four reprogramming factors, OCT3/4, SOX2, KLF4, and c-MYC). Cells were proliferated on vitronectin (Thermo) coated Tissue Culture Polystyrene (TCPS) dishes in Essential-8 (Gibco) culture medium [8]. For proliferation, cells were seeded at a 10,000 cells/cm2 density and were subcultured at 80%

Functional characterization of CPM+ HLCs

In this work, the CPM+ sorted HLCs matured and described in conventional culture dishes by [25] were seeded in PDMS microfluidic biochips. After sorting on day 2, the cells exhibited a typical morphology of liver progenitor cells (LPCs) and evolved toward an hepatoblast-like morphology after maturation and subcultures as described (Fig. 1 A). After 12 days of maturation in microfluidic biochip, the CPM+ HLCs tissue presented several distinct morphologies (Fig. 1B). Especially, zones in which

Discussion

Previously published strategies in our group [11], [12] were based on the conviction that cellular heterogeneity, caused by the differentiation process, would lead to an improved maturation due to the presence of non-parenchymal cells sharing the same ascendance. However, in both monoculture and in coculture with non-parenchymal cells, primitive patterns were still found to be dominant and further differentiation did not lead to any specific improvement. In that regard, CPM+ was previously

Conclusion

In the present manuscript, a new protocol combining the differentiation and maturation of CPM+ HLCs with the organ on chip technology has been proposed. While the tissue still exhibited immature feature such as the high expression of AFP, significant improvement was observed in terms of function when compared to unsorted HLCs culture in similar conditions. The analysis of the transcriptomic, proteomic and metabolomic profiles contributed to clearly separate both conditions and further confirmed

Ethical issue

No ethical approval was required for the work presented in this study.

CRediT authorship contribution statement

Danoy Mathieu: Conceptualization, Methodology, Investigation, Analysis, Writing. Poulain Stéphane, Jellali Rachid: Investigation, Analysis, Writing. Scheidecker Benedikt, Tauran Yannick: Investigation. Leduc Marjorie, Bruce Johanna, Gilard Francoise, Gakiere Bertrand, Arakawa Hiroshi, Kato Yukio, Kim Soo Hyeon, Kido Taketomo, Miyajima Atsushi: Resources. Sakai Yasuyuki: Resources, Funding acquisition. Leclerc Eric: Conceptualization, Writing, Supervision, Funding acquisition.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

This work was supported by the French Investissements d′Avenir in the framework of the iLite project (ANR-16-RHUS-0005). The molds used for the fabrication of the PDMS biochips were made by the LAAS in the frame of RENATECH support. Stéphane Poulain was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-aid for Scientific Research (S) 16H06328. The authors thank the FANTOM5 consortium for generously allowing the use of their PHHs RNA samples and the RIKEN Center for

References (48)

  • U. Apte et al.

    Enhanced liver regeneration following changes induced by hepatocyte‐specific genetic ablation of integrin‐linked kinase

    Hepatology

    (2009)
  • O. Arnaud et al.

    Targeted reduction of highly abundant transcripts using pseudo-random primers

    Biotechniques

    (2016)
  • S.S. Bale et al.

    Long-term coculture strategies for primary hepatocytes and liver sinusoidal endothelial cells

    Tissue Eng. Part C: Methods

    (2015)
  • P.J. Balwierz et al.

    ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs

    Genome Res.

    (2014)
  • G. Chen et al.

    Chemically defined conditions for human iPSC derivation and culture

    Nat. Methods

    (2011)
  • J. Chong et al.

    MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis

    . Nucleic Acids Res.

    (2018)
  • M. Danoy et al.

    Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment

    Biotechnol. Bioeng.

    (2019)
  • Danoy, M., Tauran, Y., Poulain, S., Jellali, R., Bruce, J., Leduc, M.,. & Leclerc, E. (2021). Multi‐omics analysis of...
  • M.A. Della Fazia et al.

    Foie GRAS and liver regeneration: a fat dilemma

    Cell Stress

    (2018)
  • E.W. Esch et al.

    Organs-on-chips at the frontiers of drug discovery

    Nat. Rev. Drug Discov.

    (2015)
  • O. Fiehn

    Metabolite profiling in Arabidopsis

    Arabidopsis Protocols

    (2006)
  • O. Fiehn et al.

    Quality control for plant metabolomics: reporting MSI‐compliant studies

    Plant J.

    (2008)
  • S.X. Ge et al.

    iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data

    BMC Bioinforma.

    (2018)
  • G.G. Giobbe et al.

    Functional differentiation of human pluripotent stem cells on a chip

    Nat. Methods

    (2015)
  • View full text